Ellen Phillips, MD
Obstetrics & Gynecology · Dothan, ALNPI 1487699716
Payments from drug & device makers
Across 114 payments — averaging $18.87 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$622
- Astellas Pharma US Inc$314
- Sumitomo Pharma America, Inc.$205
- Hologic Sales And Service, LLC$165
- Exeltis, USA Inc.$111
- Scynexis, Inc.$66
- plus $667 from 21 others
What the payments were for
- Food & beverage$2,03294%
- Education$1196%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 31 | $622 |
| Astellas Pharma US Inc | 13 | $314 |
| Sumitomo Pharma America, Inc. | 10 | $205 |
| Hologic Sales And Service, LLC | 10 | $165 |
| Exeltis, USA Inc. | 6 | $111 |
| Scynexis, Inc. | 4 | $66 |
| Sage Therapeutics, LLC | 3 | $58 |
| Lupin Inc. | 3 | $56 |
| Therapeuticsmd, Inc. | 4 | $56 |
| Urovant Sciences Inc | 3 | $53 |
| Axonics, Inc. | 1 | $43 |
| Bayer | 3 | $43 |
| Solventum Corporation | 2 | $41 |
| Daiichi Sankyo Inc. | 3 | $40 |
| Organon | 2 | $36 |
| Merck | 2 | $35 |
| Pfizer | 2 | $29 |
| Myovant Sciences Inc. | 2 | $27 |
| Amgen | 2 | $26 |
| Roche Diagnostics Corporation | 1 | $20 |
| Bard Access Systems, Inc. | 1 | $19 |
| Dexcom, Inc. | 1 | $19 |
| Duchesnay USA Incorporated | 1 | $15 |
| Next Science LLC | 1 | $15 |
| Shield Therapeutics Inc | 1 | $14 |
| Medtronic | 1 | $12 |
| Avion Pharmaceuticals | 1 | $11 |
How this compares
$2,151 in reported general payments places this provider in the 60th percentile of 537 obstetrics & gynecology providers in Alabama.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Estradiol | 86 | $2,883 |
| Tolterodine Tartrate | 11 | $984 |
| Terconazole | 16 | $500 |
| Dilt-XrDiltiazem Hcl | 11 | $344 |
| Solifenacin Succinate | 16 | $301 |
| Medroxyprogesterone Acetate | 27 | $266 |
| ValacyclovirValacyclovir Hcl | 17 | $249 |
| NitrofurantoinNitrofurantoin Macrocrystal | 20 | $192 |
| Fluconazole | 28 | $187 |
| Triamcinolone Acetonide | 14 | $160 |
| Escitalopram Oxalate | 12 | $152 |
| Oxybutynin Chloride | 12 | $93 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 11 | $31 |
| Citalopram HbrCitalopram Hydrobromide | 14 | $17 |
Paid to pharmacies, not to this prescriber.
Other obstetrics & gynecology in Dothan
- Guy MiddletonDothan$5.6M
- Praful PatelDothan$81K
- Scott GilchristDothan$53K
- Matthew RaganDothan$11K
- Allison MarkerDothan$9K
- Charles SharpBirmingham$2.8M
- John WidemanCullman$2.3M
- Charles RogersMobile$1.8M
- Ronald OrsoBirmingham$1.6M
- Amy McCoyMobile$1.2M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.